Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5 (Search time: 0.001 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Doxorubicin overcomes resistance to drozitumab by antagonizing inhibitor of apoptosis proteins (IAPS)Zinonos, I.; Labrinidis, A.; Liapis, V.; Hay, S.; Panagopoulos, V.; Denichilo, M.; Ponomarev, V.; Ingman, W.; Atkins, G.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2014Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancerZinonos, I.; Luo, K.; Labrinidis, A.; Liapis, V.; Hay, S.; Panagopoulos, V.; Denichilo, M.; Ko, C.; Yue, G.; Lau, C.; Ingman, W.; Ponomarev, V.; Atkins, G.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2016Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine modelsLiapis, V.; Zinonos, I.; Labrinidis, A.; Hay, S.; Ponomarev, V.; Panagopoulos, V.; Zysk, A.; DeNichilo, M.; Ingman, W.; Atkins, G.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2017Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancerZysk, A.; DeNichilo, M.; Panagopoulos, V.; Zinonos, I.; Liapis, V.; Hay, S.; Ingman, W.; Ponomarev, V.; Atkins, G.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2017Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcomaLiapis, V.; Zysk, A.; DeNichilo, M.; Zinonos, I.; Hay, S.; Panagopoulos, V.; Shoubridge, A.; Difelice, C.; Ponomarev, V.; Ingman, W.; Atkins, G.; Findlay, D.; Zannettino, A.; Evdokiou, A.